(Q57549090)

English

Quantitative monitoring of tamoxifen in human plasma extended to 40 metabolites using liquid-chromatography high-resolution mass spectrometry: new investigation capabilities for clinical pharmacology

scholarly article by Elyes Dahmane et al published April 2014 in Analytical and Bioanalytical Chemistry

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Quantitative monitoring of tamoxifen in human plasma extended to 40 metabolites using liquid-chromatography high-resolution mass spectrometry: new investigation capabilities for clinical pharmacology (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Chantal Csajka

3

0 references

Laurent Arthur Decosterd

object named as

Laurent Décosterd

5

0 references

10

object named as

Bernard Testa

0 references

2

object named as

Julien Boccard

0 references

4

object named as

Serge Rudaz

0 references

author name string

Elyes Dahmane

1

0 references

Eric Genin

6

0 references

Bénédicte Duretz

7

0 references

Maciej Bromirski

8

0 references

Khalil Zaman

9

0 references

Bertrand Rochat

11

0 references

language of work or name

0 references

publication date

April 2014

0 references

16 March 2014

0 references

Analytical and Bioanalytical Chemistry

0 references

406

0 references

11

0 references

2627-40

0 references

2627-2640

0 references

The cost of adverse drug reactions

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

The biochemistry of drug metabolism--an introduction: part 5. Metabolism and bioactivity

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

The generation, detection, and effects of reactive drug metabolites

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Mechanisms of Drug Toxicity and Relevance to Pharmaceutical Development

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

The biochemistry of drug metabolism--an introduction: part 6. Inter-individual factors affecting drug metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

The biochemistry of drug metabolism--an introduction: part 7. Intra-individual factors affecting drug metabolism.

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Investigational study of tamoxifen phase I metabolites using chromatographic and spectroscopic analytical techniques.

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Reactions and enzymes in the metabolism of drugs and other xenobiotics

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Bioanalytical methods for determination of tamoxifen and its phase I metabolites: A review

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Comparison between a high-resolution single-stage Orbitrap and a triple quadrupole mass spectrometer for quantitative analyses of drugs

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

The future key role of LC-high-resolution-MS analyses in clinical laboratories: a focus on quantification

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Comprehensive comparison of liquid chromatography selectivity as provided by two types of liquid chromatography detectors (high resolution mass spectrometry and tandem mass spectrometry): "where is the crossover point?".

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Integration of knowledge-based metabolic predictions with liquid chromatography data-dependent tandem mass spectrometry for drug metabolism studies: application to studies on the biotransformation of indinavir

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

4-Hydroxytamoxifen sulfation metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Activity Levels of Tamoxifen Metabolites at the Estrogen Receptor and the Impact of Genetic Polymorphisms of Phase I and II Enzymes on Their Concentration Levels in Plasma

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

The biochemistry of drug metabolism--an introduction: Part 2. Redox reactions and their enzymes

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Drug glucosidation

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

The biochemistry of drug metabolism--an introduction: part 4. reactions of conjugation and their enzymes

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Vertebrate UDP-glucuronosyltransferases: functional and evolutionary aspects

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Acyl glucuronidation and glucosidation of a new and selective endothelin ET(A) receptor antagonist in human liver microsomes

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Metabolism and pharmacokinetics of naronapride (ATI-7505), a serotonin 5-HT(4) receptor agonist for gastrointestinal motility disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Imatinib metabolite profiling in parallel to imatinib quantification in plasma of treated patients using liquid chromatography-mass spectrometry.

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-7682-2

21 January 2018

Identifiers

10.1007/S00216-014-7682-2

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57549090&oldid=2213520991"